These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 2086386

  • 1. Iron metabolism in thalassemia intermedia.
    Fiorelli G, Fargion S, Piperno A, Battafarano N, Cappellini MD.
    Haematologica; 1990; 75 Suppl 5():89-95. PubMed ID: 2086386
    [Abstract] [Full Text] [Related]

  • 2. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P, Giua R, De Marco S, Bonetti MG, Amurri B, Masi C, Lazzari G, Rizzo C, Cervellera M, Peluso A.
    Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Chelating therapy in beta-thalassemia].
    Musumeci S, Romeo MA, Di Gregorio F, Schiliró G, Russo G.
    Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
    [Abstract] [Full Text] [Related]

  • 6. [Nuclear magnetic resonance and iron overload in thalassemia].
    Schettini F, De Mattia D, Cavallo L, Sabato V, Santoro N, Del Vecchio GC, Martinelli G, Martinelli A, Di Bartolomeo P, Di Girolamo G.
    Minerva Pediatr; 1991 Dec; 43(12):777-81. PubMed ID: 1798402
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
    Giardina PJ, Grady RW.
    Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288
    [Abstract] [Full Text] [Related]

  • 9. Iron chelating therapy in thalassemia: current problems.
    Russo G.
    Haematologica; 1990 Oct; 75 Suppl 5():84-8. PubMed ID: 2086385
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Iron chelation in thalassemia: mechanism of desferrioxamine action.
    Hershko C, Rachmilewitz EA.
    Isr J Med Sci; 1978 Nov; 14(11):1111-5. PubMed ID: 750535
    [Abstract] [Full Text] [Related]

  • 12. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major.
    Grosse R, Lund U, Caruso V, Fischer R, Janka GE, Magnano C, Engelhardt R, Dürken M, Nielsen P.
    Ann N Y Acad Sci; 2005 Nov; 1054():429-32. PubMed ID: 16339692
    [Abstract] [Full Text] [Related]

  • 13. High nontransferrin bound iron levels and heart disease in thalassemia major.
    Piga A, Longo F, Duca L, Roggero S, Vinciguerra T, Calabrese R, Hershko C, Cappellini MD.
    Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228
    [Abstract] [Full Text] [Related]

  • 14. Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia.
    Taher A, Musallam KM, El Rassi F, Duca L, Inati A, Koussa S, Cappellini MD.
    Br J Haematol; 2009 Sep; 146(5):569-72. PubMed ID: 19604239
    [Abstract] [Full Text] [Related]

  • 15. Clinical studies on iron chelation in patients with thalassemia major.
    Freedman MH, Olivieri N, Benson L, Liu P, McClelland R, St Louis P, Templeton D, Koren G.
    Haematologica; 1990 Sep; 75 Suppl 5():74-83. PubMed ID: 2086384
    [No Abstract] [Full Text] [Related]

  • 16. [Iron overload in a beta thalassemia heterozygote of the intermediate type in a subject of Alsation origin. Results of iron chelation treatment].
    North ML, Lang JM, Bergerat JP, Giron C, Oberling F, Mayer S.
    Nouv Rev Fr Hematol (1978); 1984 Sep; 26(5):317-21. PubMed ID: 6334273
    [Abstract] [Full Text] [Related]

  • 17. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
    Gaziev J, Sodani P, Polchi P, Andreani M, Lucarelli G.
    Ann N Y Acad Sci; 2005 Sep; 1054():196-205. PubMed ID: 16339666
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of iron balance in homozygous beta-thalassemia subjects treated with desferrioxamine administered subcutaneously].
    Ferrara M, Galdo Capotorti M, Ponte G, Esposito L.
    Pediatria (Napoli); 1983 Sep; 91(4):371-7. PubMed ID: 6545400
    [No Abstract] [Full Text] [Related]

  • 19. Retrospective clinical remarks in thalassemia intermedia.
    Dore F, Cianciulli P, Oggiano L, Pardini S, Bonfigli S, Ganau A, Piga G, Trua G, Papa G, Longinotti M.
    Haematologica; 1990 Sep; 75 Suppl 5():9-25. PubMed ID: 2086387
    [No Abstract] [Full Text] [Related]

  • 20. Desferrioxamine induced urinary iron excretion in thalassemia.
    Dubey AP, Kumar S, Choudhury P, Talukdar B, Puri RK.
    Indian Pediatr; 1993 Jun; 30(6):775-8. PubMed ID: 8132258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.